Anika Therapeutics (ANIK) Other Non-Current Liabilities (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly Other Non-Current Liabilities came in at $730000.0 in Q2 2026, down 3.44% year-over-year from $756000.0 in Q2 2025, and up 0.55% quarter-over-quarter from $726000.0 in Q1 2026.
Powered by 
Analysis
Anika Therapeutics (ANIK) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Other Non-Current Liabilities for 17 consecutive years, with $730000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 3.44% year-over-year to $730000.0 in Q2 2026; TTM through Jun 2026 was $730000.0, a 3.44% decrease from a year earlier, with the FY2025 full-year figure at $701000.0, down 9.2% from the prior year.
- Other Non-Current Liabilities was $730000.0 for Q2 2026 at Anika Therapeutics, up from $726000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $806000.0 in Q3 2024 and troughed at $398000.0 in Q4 2022.
- A 5-year average of $586333.3 and a median of $635500.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities tumbled 96.53% in 2022 and soared 101.5% in 2024, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $398000.0 in 2022, then rose by 1.51% to $404000.0 in 2023, then soared by 91.09% to $772000.0 in 2024, then retreated by 9.2% to $701000.0 in 2025, then grew by 4.14% to $730000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $730000.0 (Q2 2026), $726000.0 (Q1 2026), and $701000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 730,000.00 |
| Mar 31, 2026 | 726,000.00 |
| Dec 31, 2025 | 701,000.00 |
| Sep 30, 2025 | 761,000.00 |
| Jun 30, 2025 | 756,000.00 |
| Mar 31, 2025 | 744,000.00 |
| Dec 31, 2024 | 772,000.00 |
| Sep 30, 2024 | 806,000.00 |
| Jun 30, 2024 | 407,000.00 |
| Mar 31, 2024 | 404,000.00 |
| Dec 31, 2023 | 404,000.00 |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 401,000.00 |
| Mar 31, 2023 | 399,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Jun 30, 2022 | 587,000.00 |
| Mar 31, 2022 | 684,000.00 |
| Dec 31, 2021 | 1.26 Mn |
| Sep 30, 2021 | 1.49 Mn |